Syndicate This week's upcoming IPO's and secondary offerings

Week of February 5 to February 9, 2025

This Week's Deals to be Priced

02/07 - Wednesday

Symbol

Issuer

Type

Price

Managers

TFG

Fortegra
Fortegra
IPO
Postponed $15.00-18.00
18M
Goldman Sachs & JPMorgan,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs & JPMorgan, Barclays, JMP Securities, Keefe Bruyette, Piper Sandler, Raymond James, Fifth Third

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Priced Deals

02/05 - Monday

Symbol

Issuer

Type

Price

Managers

HESM

Hess Midstream LP
Hess Midstream LP
Spot Secondary
Priced: $33.10
10M
Citi

Pricing after close
Deal analysis and details

Managers: Citi

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
IMMX

Immix Biopharma
Immix Biopharma
Spot Secondary
Priced: $2.71
5.5M
Titan Partners

Pricing after close

Managers: Titan Partners

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

02/06 - Tuesday

Symbol

Issuer

Type

Price

Managers

AHR

American Healthcare REIT
American Healthcare REIT
IPO
Priced: $12.00
56M
BofA,...

Pricing after close
Deal analysis and details

Managers: BofA, Morgan Stanley, KeyBanc, Citi, RBC Capital, Barclays & Truist

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
FDMT

4D Molecular
4D Molecular
Secondary
Priced: $29.50
6.59M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, BofA, Jefferies & Barclays

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
PEPG

PepGen
PepGen
Secondary
Priced: $10.635
7.53M
Leerink

Pricing after close

Managers: Leerink

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
JSPR

Jasper Therapeutics
Jasper Therapeutics
Spot Secondary
Priced: $12.95
3.9M
TD Cowen & Evercore ISI

Pre-open pricing
Deal analysis and details

Managers: TD Cowen & Evercore ISI

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MLNK

MeridianLink
MeridianLink
Spot Secondary
Priced: $19.00
6.9M
Citi & JPMorgan

Pricing after close
Deal analysis and details

Managers: Citi & JPMorgan

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
REKR

Rekor Systems
Rekor Systems
Spot Secondary
Priced: $2.50
10M
William Blair,...

Pricing after close
Deal analysis and details

Managers: William Blair, Northland

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

02/07 - Wednesday

Symbol

Issuer

Type

Price

Managers

KYTX

Kyverna Therapeutics
Kyverna Therapeutics
IPO
Priced: $22.00
14.5M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, Morgan Stanley, Leerink & Wells Fargo

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
PMNT

Perfect Moment
Perfect Moment
IPO
Priced: $6.00
1.33M
ThinkEquity & Laidlaw

Pricing after close
Deal analysis and details

Managers: ThinkEquity & Laidlaw

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
AUTL

Autolus Therapeutics
Autolus Therapeutics
Secondary
Priced: $6.00
58.3M
Jefferies & Truist,...

Pricing after close

Managers: Jefferies & Truist, MIZU, Needham

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TENX

Tenax Therapeutics
Tenax Therapeutics
Secondary
Priced: $5.65
1.6M
Roth MKM

Pricing after close

Managers: Roth MKM

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TNYA

Tenaya Therapeutics
Tenaya Therapeutics
Secondary
Priced: $4.50
8.888M
Leerink & TD Cowen

Pricing after close

Managers: Leerink & TD Cowen

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SANA

Sana Biotechnology
Sana Biotechnology
Spot Secondary
Priced: $5.50
17.3M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley, JPMorgan, Goldman Sachs & BofA

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

02/08 - Thursday

Symbol

Issuer

Type

Price

Managers

MGX

Metagenomi
Metagenomi
IPO
Priced: $15.00
6.25M
JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, Jefferies, TD Securities, Wells Fargo, BMO Capital & Chardan

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TBBB

BBB Foods
BBB Foods
IPO
Priced: $17.50
33.661M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, Morgan Stanley, BofA, Scotiabank & UBS

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CVM

CEL-SCI
CEL-SCI
Secondary
Priced: $2.00
3.875M
ThinkEquity

Pricing after close

Managers: ThinkEquity

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
EVOK

Evoke Pharma
Evoke Pharma
Secondary
Priced: $.68
11M
Craig-Hallum & Laidlaw

Pricing after close

Managers: Craig-Hallum & Laidlaw

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access